| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/29/1999 | US5916793 Arginine deiminase derived from Mycoplasma arthritidis and polymer conjugates containing the same |
| 06/29/1999 | US5916792 Jak3 plays a role in the growth factor modulated differentiation/proliferation of the stem/progenitor cells. |
| 06/29/1999 | US5916778 Diagnostics based on a glaucoma causing gene |
| 06/29/1999 | US5916773 Recombinant production of fusion proteins comprising erythropoietin and GM-CSF components |
| 06/29/1999 | US5916769 Polynucleotides encoding extra cellular/epidermal growth factor HCABA58X polypepides |
| 06/29/1999 | US5916767 DNA encoding human interleukin-5 receptor |
| 06/29/1999 | US5916766 Human marco scavenger receptor |
| 06/29/1999 | US5916764 Human phosphatidylinositol synthase |
| 06/29/1999 | US5916760 IKK-β proteins, nucleic acids and methods |
| 06/29/1999 | US5916756 Assay of connective tissue growth factor for detection of cell proliferative disorders |
| 06/29/1999 | US5916755 Relates to genes which encode novel proteins related to a family of receptor proteins typified by two related membrane spanning tyrosine kinases: the epidermal growth factor receptor, which is encoded by the erbb gene, and the receptor |
| 06/29/1999 | US5916754 Detecting infection |
| 06/29/1999 | US5916753 Nucleic acid and amino acid sequences of two sh3-containing proteins and to the use of these sequences in the diagnosis, prevention, and treatment of cancer, and immune and developmental disorders. |
| 06/29/1999 | US5916752 Telomerase screening methods |
| 06/29/1999 | US5916589 Pharmaceutical compositions comprising cyclosporins |
| 06/29/1999 | US5916582 Aqueous formulations of peptides |
| 06/29/1999 | US5916569 Human erectile dysfunction and methods of treatment |
| 06/29/1999 | US5916566 Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds |
| 06/29/1999 | US5916565 Antiarthritic agent consists of a palatability agent, cayenne, ginger, yucca roots, devil's claw, black cohosh, nettle leaf, tumeric, alfalfa, celery seeds, glucosamine hydrochlorie and mucopolysaccharide |
| 06/29/1999 | US5916561 Monoclonal antibody against CD44v6 |
| 06/29/1999 | US5916560 Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith |
| 06/29/1999 | US5916559 For organ transplants |
| 06/29/1999 | US5916557 Methods of repairing connective tissues |
| 06/29/1999 | US5916556 Human MRNA editing enzyme |
| 06/29/1999 | US5916539 Superparamagnetic particles, process for producing the same and their use |
| 06/29/1999 | US5915378 Creating an aerosolized formulation of insulin |
| 06/29/1999 | CA2225881A1 Human umbilical cord blood as a source of hemoglobin for use as a hemoglobin-based oxygen carrier |
| 06/29/1999 | CA2125974C Senescent cell derived inhibitors of dna synthesis |
| 06/29/1999 | CA2048200C Polylactide in a purified state, method for the production therof, and pharmaceutical compositions |
| 06/29/1999 | CA2016584C Anthracycline conjugates having a novel linker and methods for their production |
| 06/29/1999 | CA1340612C Cell specific cytotoxic agents derived from diphtheria toxin |
| 06/29/1999 | CA1340611C Recombinant alveolar surfactant protein |
| 06/24/1999 | WO1999031253A2 Novel flea epoxide hydrolase nucleic acid molecules, proteins and uses thereof |
| 06/24/1999 | WO1999031252A1 Ubiquitin-like conjugating protein |
| 06/24/1999 | WO1999031247A1 Bacterial fibrin-dependent plasminogen activator |
| 06/24/1999 | WO1999031246A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 06/24/1999 | WO1999031245A1 Epithelial cell binding proteins obtainable from group b streptococcal strain and encoding dna |
| 06/24/1999 | WO1999031241A1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 06/24/1999 | WO1999031240A2 14-3-3σ ARRESTS THE CELL CYCLE |
| 06/24/1999 | WO1999031237A1 Apoptosis inhibitory factor |
| 06/24/1999 | WO1999031233A1 Polypeptides, polynucleotides and uses thereof |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031231A1 p53 REGULATORY PROTEIN CALLED RB18A AND USES THEREOF |
| 06/24/1999 | WO1999031230A2 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | WO1999031229A2 Peptides and nucleic acids derived from eisenia foetida and the use thereof |
| 06/24/1999 | WO1999031228A1 Application of subtractive hybridization in screening for colore ctal cancer negatively related gene |
| 06/24/1999 | WO1999031227A2 NOVEL PEPTIDE, apoEp1.B, COMPOSITIONS AND USES THEREOF |
| 06/24/1999 | WO1999031225A2 Human phosphatases |
| 06/24/1999 | WO1999031140A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/24/1999 | WO1999031138A1 Method for preparing by filtration a virally secure factor viii solution |
| 06/24/1999 | WO1999031136A2 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
| 06/24/1999 | WO1999031135A1 Proteins for cancer cell specific induction of apoptosis and method for isolation thereof |
| 06/24/1999 | WO1999031134A1 Glucose regulated gene |
| 06/24/1999 | WO1999031133A1 Novel abc transporter |
| 06/24/1999 | WO1999031132A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS) |
| 06/24/1999 | WO1999031130A1 Galanin receptor galr3 and nucleotides encoding same |
| 06/24/1999 | WO1999031128A2 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | WO1999031127A1 Cyclopeptolides |
| 06/24/1999 | WO1999031126A1 Cyclopeptide derivatives with integrin inhibitor properties |
| 06/24/1999 | WO1999031125A1 Wound healing compositions |
| 06/24/1999 | WO1999031123A1 Antifungal and antibacterial peptides |
| 06/24/1999 | WO1999031122A1 Antipicornaviral compounds and methods for their use and preparation |
| 06/24/1999 | WO1999031119A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes |
| 06/24/1999 | WO1999031118A1 Inhibition of tumor cells proliferation using ribozymes |
| 06/24/1999 | WO1999031117A1 110 human secreted proteins |
| 06/24/1999 | WO1999031116A1 Human dendriac and brainiac-3 |
| 06/24/1999 | WO1999031083A1 PHOTOCHROMIC INDENO-FUSED NAPHTHO[2,1-b]PYRANS |
| 06/24/1999 | WO1999031052A1 Novel metalloproteinase inhibitors |
| 06/24/1999 | WO1999031049A1 Neuroprotective agents |
| 06/24/1999 | WO1999030738A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | WO1999030736A2 Methods to treat undesirable immune responses |
| 06/24/1999 | WO1999030735A1 UGC (UPSTREAM GENE OF cdsA) |
| 06/24/1999 | WO1999030734A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity |
| 06/24/1999 | WO1999030732A1 Gamma-conopeptides |
| 06/24/1999 | WO1999030731A1 Glucagon-like peptide-1 crystals |
| 06/24/1999 | WO1999030730A1 Methods and compositions for improving the success of cell transplantation in a host |
| 06/24/1999 | WO1999030729A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | WO1999030728A1 Pharmaceutical compositions based on dalforpristin and quinupristin and preparation |
| 06/24/1999 | WO1999030727A1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 06/24/1999 | WO1999030726A1 Improved method for attaching dental and orthopedic implants, ligaments, and tendons to bone |
| 06/24/1999 | WO1999030716A1 The use of nitric oxide generations for the treatment of dry eye disorders |
| 06/24/1999 | WO1999030699A1 Modulators of cysteine protease |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | WO1999030648A1 Pluripotential bone marrow cell line and methods of using the same |
| 06/24/1999 | WO1999030562A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
| 06/24/1999 | WO1999020654A3 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT |
| 06/24/1999 | WO1999019490A9 Apo-3 ligand |
| 06/24/1999 | WO1999019480A3 Human receptor proteins; related reagents and methods |
| 06/24/1999 | WO1999019359A9 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 06/24/1999 | WO1999019352A3 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids |
| 06/24/1999 | WO1999018197A3 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced) |
| 06/24/1999 | WO1999016888A3 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 06/24/1999 | WO1999016787A9 Cell death agonists |
| 06/24/1999 | WO1999007728A3 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 06/24/1999 | WO1998051792A8 Fac molecules and uses thereof |
| 06/24/1999 | WO1998018951A8 Receptor-mediated gene transfer system for targeting tumor gene therapy |
| 06/24/1999 | DE19830914C1 Preparation of a protein solution, especially albumin solution for use as blood volume substitute in emergency situations, and solution containing blood coagulation factors |
| 06/24/1999 | CA2730373A1 Treatment of cancer having overexpression of erbb2 with anti-erbb2 antibodies and a hormonal chemotherapeutic agent |
| 06/24/1999 | CA2635158A1 Protein expression in baculovirus vector expression systems |
| 06/24/1999 | CA2348660A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |